G4A Tokyo" is a life science theme that presents a different challenge each time and invites digital health startups to come up with innovative solutions to each challenge.
In this seventh program, issues were presented from the three areas of oncology, cardiovascular, and R&D. Pipon tackled the R&D (pharmaceutical affairs) area issue of "improving efficiency in creating presentation materials" and proposed a system to solve it.
It is important for pharmaceutical companies to sort out the regulatory requirements in each country for simultaneous worldwide filing and approval of new drugs and to develop optimal regulatory strategies. These regulatory requirements are discussed in various meetings in each country or project, including an overview of the regulatory requirements, commonalities and differences, and various types of presentation materials are prepared for this purpose. In order to refer to these PPT files containing a large amount of data, time is spent manually extracting and organizing the relevant items (i.e., locating the relevant items), which has become an issue. Pipon proposed a prototype system to solve this problem.
The system prototyped by PIPON this time incorporates the following functions specified by Bayer in response to the above issues.
When a search keyword is entered, slide pages related to that keyword are displayed as thumbnails.
When selected from the list of thumbnails displayed, the content of that slide is copied to the presentation being created.
Prepare slides to match the slide master of the destination slide.
Comment from Seiya Kitazume, President of PIPON Inc.

Upon the selection of this system, MEDINET, together with Bayer Yakuhin, will conduct joint research for the practical application of this system. Bayer's goal is not only to improve the efficiency of these tasks, but also to use the system to facilitate smooth communication with internal and external stakeholders and to shorten the development process of new drugs. In line with our mission "to use technology to make the world more efficient," we will continue to contribute to the field of medicine by providing solutions that lead to more efficient business processes.
About PIPON Corporation
PIPON Inc. was founded in September 2019 with the mission of "using technology to make the world more efficient". The company provides data science support to the pharmaceutical industry.
| name of company | PIPON Corporation |
| Establishment | September 13, 2019 |
| Location | 2-1-9 Roppongi, Minato-ku, Tokyo 160-0022 |
| representative | Seiya Kitazume, President and Representative Director |
| uniform resouce locator | https://pipon.net/ |
About G4A Tokyo
G4A is an open innovation program of Bayer AG of Germany that supports the development of innovative solutions in the area of digital health. In Japan, G4A Tokyo, a local program targeting the digital health domain in Japan, started in 2016. Bayer presents life science challenges and invites innovative solutions to each challenge from digital health startups. The first four rounds of the program were grant programs to support digital health innovators, and from the fifth round onward, the "G4A Tokyo Dealmaker," a matching program with startups, is being implemented. For more information, please see below.
https://www.g4atokyo.jp








